logo
  

Infosys Partners With Economist Group To Advance Sustainability Solutions

Infosys Limited (INFY) announced Wednesday a new strategic partnership with media company The Economist Group to enable and accelerate sustainability solutions.

Infosys, as Digital Innovation Partner, will power Economist Group's latest global initiative to advance the discourse on sustainability amongst world leaders and businesses.

The companies plan to drive world-changing impact through a new business-to-business model. The initiative is designed to unlock the long-term thinking of businesses and other institutions.

The first phase of the strategic, multi-year partnership will be announced and launched in October 2021. Infosys' groundbreaking digital services and capabilities will be combined with the strength and depth of Economist Group's policy research, insights and events expertise.

Lara Boro, CEO, Economist Group, said, "This exciting partnership with Infosys shows how pooling strengths can accelerate innovation and amplify impact in the pursuit of progress."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT